AUGXAugmedix, Inc.

Nasdaq augmedix.com


$ 1.15 $ -0.02 (-2.13 %)    

Tuesday, 14-May-2024 15:30:45 EDT
QQQ $ 446.06 $ 1.29 (0.29 %)
DIA $ 395.82 $ 0.73 (0.18 %)
SPY $ 523.36 $ 1.18 (0.23 %)
TLT $ 90.84 $ 0.24 (0.26 %)
GLD $ 218.04 $ 0.21 (0.1 %)
$ 2.34
$ 1.17
$ 1.13 x 100
$ 1.16 x 163
$ 1.11 - $ 1.21
$ 2.22 - $ 6.25
1,083,486
na
124.16M
$ 0.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 04-17-2023 12-31-2022 10-K
7 11-18-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 10-01-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-20-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lake-street-maintains-buy-on-augmedix-lowers-price-target-to-35

Lake Street analyst Brooks O'Neil maintains Augmedix (NASDAQ:AUGX) with a Buy and lowers the price target from $8 to $3.5.

 maxim-group-downgrades-augmedix-to-hold

Maxim Group analyst Allen Klee downgrades Augmedix (NASDAQ:AUGX) from Buy to Hold.

 augmedix-q1-2024-adj-eps-012-beats-013-estimate-sales-13471m-beat-13367m-estimate

Augmedix (NASDAQ:AUGX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7...

 analyst-ratings-for-augmedix
Analyst Ratings For Augmedix
04/09/2024 20:00:38

 evercore-isi-group-upgrades-augmedix-to-outperform-raises-price-target-to-5

Evercore ISI Group analyst Elizabeth Anderson upgrades Augmedix (NASDAQ:AUGX) from In-Line to Outperform and raises the pric...

 augmedix-and-sada-forge-partnership-to-scale-ambient-documentation-and-structured-data-products-to-health-systems-nationwide

Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced its go-to-market partn...

 b-riley-securities-reinstates-buy-on-augmedix-announces-55-price-target

B. Riley Securities analyst Neil Chatterji reinstates Augmedix (NASDAQ:AUGX) with a Buy and announces $5.5 price target.

 why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

 evercore-isi-group-maintains-in-line-on-augmedix-lowers-price-target-to-45

Evercore ISI Group analyst Elizabeth Anderson maintains Augmedix (NASDAQ:AUGX) with a In-Line and lowers the price target fr...

 maxim-group-maintains-buy-on-augmedix-lowers-price-target-to-5

Maxim Group analyst Allen Klee maintains Augmedix (NASDAQ:AUGX) with a Buy and lowers the price target from $6.5 to $5.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION